Showing results (1641-1650 of 6,511) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 22, 2009
Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccinesAdam S Giermasz, Julie A Urban, Yutaro Nakamura, et al.Cancer Immunology, Immunotherapy : CII|February 3, 2009
CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancerKazuaki Chikamatsu, Koichi Sakakura, Goro Takahashi, et al.Cancer Immunology, Immunotherapy : CII|February 3, 2009
The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancerTsukasa Seya, Misako MatsumotoCancer Immunology, Immunotherapy : CII|November 29, 2008
Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanomaC Christian Johansson, Suzanne Egyházi, Giuseppe Masucci, et al.Cancer Immunology, Immunotherapy : CII|January 14, 2009
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient casesAnna Maria Di Giacomo, Riccardo Danielli, Massimo Guidoboni, et al.Cancer Immunology, Immunotherapy : CII|February 14, 2009
Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitroWujiang Liu, Michael A O'Donnell, Xiaohong Chen, et al.Cancer Immunology, Immunotherapy : CII|February 18, 2009
Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma modelClaire Banissi, François Ghiringhelli, Lin Chen, et al.Cancer Immunology, Immunotherapy : CII|February 18, 2009
Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti-tumor activity: in vitro results and clinical responsesJun Zhou, Desheng Weng, Fangjian Zhou, et al.Cancer Immunology, Immunotherapy : CII|October 27, 2010
Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccinationMatteo Vergati, Vittore Cereda, Ravi A Madan, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Recombinant human interferon gamma exerts an anti-proliferative effect and modulates the expression of human leukocyte antigens A,B,C and DR in human urothelial cell linesS S Ottesen, V Ahrenkiel, J KielerPageof 652